Biostar stock: buy or sell?
February 21st, 2020
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China.
Should I buy Biostar stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. That's why is so important to define your own trading plan that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Biostar Pharmaceuticals stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Biostar stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't detect any rating for BSPM stock for the last month.
Biostar stock analysis
Shares of Biostar Pharmaceuticals closed today at $0.08 and climbed an exceptional 14.29%.
Shares of Biostar climbed an exceptional 14.29% and closed at $0.08.
After sliding a bloodcurdling -42.86% in a week last week, Biostar Pharmaceuticals closed this week at $0.08 and climbed a dazzling 14.29%.
Since early February, when BSPM stock price broke down the 20-weeks moving avarage line, it slid $-0.09 per share (-52.94%).
Biostar stock price history
Biostar stock went public on December 29th, 2009 with a price of $81.901. Since then, BSPM stock declined a -99.90%, with a yearly average of -10.00%.
1: Adjusted price after possible price splits or reverse-splits.
Biostar stock historical price chart
BSPM stock reached 52-week highs at $4.07, and all-time highs 2010-04-23 with a price of 115.71.
Biostar stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we have not detected any price forecast for Biostar Pharmaceuticals stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, when Biostar Pharmaceuticals posted its last earnings report, it . As soon as we get its posted EPS from the earnings report, we will update this report.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2015, last anual revenues report draw a dreadful drop down of -91.21% to $2.38 M USD. When comparing 2016 vs 2015, in the same way, profit margin (that is, the net income divided by revenues) collapsed a -146.41% to -238.98%.
|2012||$49 M||-||$-20.00 M-40.6%||-|
|2013||$53 M||6.91%||$0.81 M1.5%||-104.05%|
|2014||$61 M||16.48%||$4.85 M7.9%||499.25%|
|2015||$27 M||-55.83%||$-25.11 M-92.6%||-617.98%|
|2016||$2.38 M||-91.21%||$-5.70 M-239.0%||-77.31%|
Quarterly financial resultsReported quarter earnings marked M with a profit margin of . Profit margin remained constant a 0.00% compared to previous quarter when profit margin was nan%. When comparing revenues to same quarter last year, Biostar Pharmaceuticals sales marked a neutral movement and stayed stable a nan%. Looking back to recent quarterly results, Biostar Pharmaceuticals posted 6 negative quarters in a row.
|2016-Q3||$0.64 M||-||$-1.56 M-241.9%||-|
|2016-Q4||$0.32 M||-50.72%||$3.39 M1066.1%||-317.18%|
Biostar ownershipWhen you are planning to buy shares of a stock, it's worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Biostar, 16.19% of all outstanding shares are owned by its staff.
In case of Biostar Pharmaceuticals stock, 0.00% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for BSPM stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Biostar:
|Market cap||$0.2 M|
|Total shares||2.6 M|
|Float shares||2.2 M|
|- Institutional holdings (%)||0.0%|
|- Insider holdings (%)||16.2%|
|Shares in short selling||0.0%|
|Friday, February 21st, 2020|
|Day range||$0.08 - $0.15|
|Average true range||$0.07|
|50d mov avg||$0.13|
|100d mov avg||$0.20|
|200d mov avg||$0.83|
Biostar performanceTo better understand Biostar Pharmaceuticals performance you must compare its gains with other related stocks in same sector or industry. We compared Biostar Pharmaceuticals against in the following table: